SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-13-033646
Filing Date
2013-04-26
Accepted
2013-04-26 17:25:18
Documents
13
Period of Report
2013-06-25
Effectiveness Date
2013-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A a13-1740_1def14a.htm DEF 14A 1928632
2 GRAPHIC g17401bqi001.jpg GRAPHIC 38089
3 GRAPHIC g17401bqi002.jpg GRAPHIC 4909
4 GRAPHIC g17401bqi003.jpg GRAPHIC 5925
5 GRAPHIC g17401bqi004.jpg GRAPHIC 7789
6 GRAPHIC g17401bmi001.jpg GRAPHIC 9521
7 GRAPHIC g17401boi001.jpg GRAPHIC 10842
8 GRAPHIC g17401boi002.jpg GRAPHIC 7069
9 GRAPHIC g17401boi003.jpg GRAPHIC 6175
10 GRAPHIC g17401boi004.jpg GRAPHIC 6714
11 GRAPHIC g17401cei001.gif GRAPHIC 46937
12 GRAPHIC g17401cei002.gif GRAPHIC 42514
13 GRAPHIC g17401bki001.jpg GRAPHIC 31865
  Complete submission text file 0001104659-13-033646.txt   2232254
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19125 | Film No.: 13788451
SIC: 2834 Pharmaceutical Preparations